PhRMA sues Biden administration over Medicare price negotiations; Huntington's treatment trial takes puzzling turn

Taking stock of the drug industry, from the lab to the medicine chest

June 21, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Graeme Sloan/Sipa USA STAT+ | PhRMA sues Biden administration over Medicare drug price negotiation program The pharmaceutical industry's biggest lobbying group filed a lawsuit challenging Democrats' Medicare drug pricing law. By Rachel Cohrs Sen. Grassley calls on GOP leaders to rally support for PBM reforms Republican Sen. Chuck Grassley wants to see his party's leadership turn up the pressure on pharmacy benefit managers. By Sarah Owermohle STAT+ | After promising early data, gene therapy trial for Huntington's takes puzzling turn Uniqure's gene therapy for Huntington's disease offers promising but difficult to interpret data for the neurodegenerative condition. By Jason Mast John Moore/Getty Images STAT+ | Drug middlemen catch flak at another congressional hearing In a House hearing, rural lawmakers jab at the huge pharmacy benefit managers, and some hospitals, too. By John Wilkerson STAT+ | One of biotech's biggest financiers launches small-molecule startup, in spite of IRA's looming shadow Empress Therapeutics seeks out genetic sequences that produce chemical compounds in the body — chemistry Empress' drugs will then hone in on. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser